RussiaDrug development

Russian start-up gets rights to develop and commercialise Roche HIV treatments

Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

14 Oct 2009

News

Subscribe to RussiaDrug development

Get the free Science|Business newsletters

Receive our Policy Bulletin each Tuesday & Thursday and news about bridging Europe’s east-west innovation gap twice a month in The Widening.

Jobs

Eureka is seeking a Process Expert Evaluation and Ethics

Climate news

Read our expanding news coverage of climate technologies and policies here.

News
- The Widening
- R&D Policy
- Health
- Energy
- Climate
- Digital
- Defence
Reports
Events
The Network
Communications Services
About Us
- Contact
- Team
- Privacy
- Careers